Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00863226
Recruitment Status : Unknown
Verified December 2011 by pico-tesla Magnetic Therapies, LLC. Recruitment status was: Active, not recruiting
The purpose of this study is to see if a device called the Resonator can help to improve aspects of health and quality of life that are relevant to patients with Parkinson's disease.
Condition or disease
Parkinson's DiseaseQuality of Life
Device: Resonator Device
This clinical trial will evaluate a new non-invasive, non-significant risk, device therapy as an adjuvant symptomatic treatment for some of the signs and or symptoms of Parkinson's Disease (PD). The device utilizes patented technology involving extremely low level electromagnetic fields.
A Randomized, Double-Blind, Sham-Stimulation Controlled Study of the Application of Magnetic Fields Using the Resonator Device for the Treatment of Parkinson's Disease: Phase Three Clinical Trial Protocol
Study Start Date :
Estimated Primary Completion Date :
Estimated Study Completion Date :
Resource links provided by the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
30 Years to 85 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Idiopathic Parkinson's Disease
Stable optimized anti-PD drugs for at least 4 weeks
PDQ-39 Summary Index between 15 and 45
Willing to maintain regular medication regime throughout study
Able to abstain from starting in new treatments to improve PD symptoms during course of study.
No prior surgical interventions for Parkinson's Disease
Minimum of 30 years of age, but not older than 85
Capable of giving full written consent
Atypical Parkinsonism such as progressive supranuclear palsy, multiple system atrophy, CBDG etc.
Subjects may not have any of the following: active brain tumor, strokes, hydrocephalus, any other neurologic or non-neuro problem which may affect symptomatic expression of patients parkinsonism.
Consumption of medications that can produce drug induced parkinsonism
Chronic pain not associated with PD
Current or past history of major psychiatric disturbance
No typical or non-typical anti-psychotics for treatment of drug induced psychosis.
Epilepsy or history of epilepsy
Seizures or taking medication for epilepsy
HIV or other autoimmune disorders
History of ECT
Advanced pulmonary disease
Unstable cardiac disease
Prior surgical interventions for Parkinson's disease
Prosthetics or implants comprised of ferrous metals
Pacemaker, vagus nerve stimulators, or other functional electrical stimulators such as those commonly used for pain
Pregnant, breast feeding or planning pregnancy prior to study end
Dementia, developmental disability, psychiatric disorder or other cognitive impairment
Any significant medical condition that may require alteration of medical therapy during the study, or major medical condition which may interfere with the study activity.